Chicago Capital LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Chicago Capital LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 34,176 shares of the medical equipment provider’s stock after acquiring an additional 2,601 shares during the period. Chicago Capital LLC’s holdings in Intuitive Surgical were worth $17,839,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $82,517,000. Exome Asset Management LLC lifted its position in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares in the last quarter. Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock valued at $132,657,000 after buying an additional 114,149 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ISRG. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, BTIG Research lifted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Trading Down 1.4 %

ISRG stock opened at $571.88 on Monday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market capitalization of $203.69 billion, a PE ratio of 89.22, a P/E/G ratio of 5.51 and a beta of 1.39. The firm has a 50-day moving average of $550.40 and a two-hundred day moving average of $509.43.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,843 shares of company stock valued at $15,357,560. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.